Volume 14, Issue 1

2023 · pp. 5–87 · 11 articles

Volume: 14
Issue: 1
Published: 2023
Pages: 5–87
Articles: 11
Sections: 3
ISSN: Print - 0976-500X, Online - 0976-5018
Journal: JPP

Review Article Research Article Case Report

In this issue

Review Article

Review
Probiotics: A Review on Microbiome That Helps for Better Health – A Dermatologist’s Perspective
Sane Roja Renuka, N. Ashok Kumar, D. Manoharan, Dama Kondaiah Naidu
pp. 5–13 · DOI: 10.1177/0976500X231175225 · Published 2023
Commensal microorganisms heavily influence human health and disease pathogenesis, and the impact of the skin microbiome on numerous skin illnesses has recently piqued researchers’ interest, in addition to the gut microbi…
Review
Food-derived Bioactive Peptides with Angiotensin-Converting Enzyme Inhibiting Effect: A Systematic Review
Albeiro Marrugo Padilla, Johana Márquez Lázaro
pp. 14–24 · DOI: 10.1177/0976500X231175217 · Published 2023
Objective: To describe the current scientific evidence of food-derived bioactive peptides and their angiotensin-converting enzyme inhibiting effect. Methods: Preferred Reporting Items for Systematic Reviews and Meta-Anal…

Research Article

Article
Evaluation of Virtual Reality High-Fidelity Adult Mannequin-based Simulation of Real-Life Clinical Scenarios in Teaching Clinical Pharmacology to Medical Students
Anupama M. Gudadappanavar, Prashant Hombal, Jyoti M. Benni, Sachin Patel, Basavaraj R. Tubaki
pp. 25–34 · DOI: 10.1177/0976500X231159456 · Published 2023
Background: Presently, competency-based medical (CBME) curriculum challenges the medical educators to provide continuing education with new approaches to make learning more stimulating, motivating, and entertaining, fost…
Article
Incidence, Patterns, and Severity of Potential Drug Interactions Among Cancer Patients on Chemotherapy in a Tertiary Care Hospital
Anuradha H.V., Vinayak V. Maka, Prakash Patil, Anupama C.
pp. 35–40 · DOI: 10.1177/0976500X231162712 · Published 2023
Objective: To study the incidence of potential drug−drug interactions (DDIs) and evaluate their pattern and severity in cancer inpatients. Materials and Methods: A detailed clinical data and prescriptions of 150 inpatien…
Article
Critical Evaluation of Drug Promotional Literature Using WHO Ethical Criteria and Perception of Clinicians at a Tertiary Care Hospital
Amanjot Kaur, Shweta Singla, Mandeep Kaur, Jasninder Singh
pp. 41–46 · DOI: 10.1177/0976500X231164812 · Published 2023
Objective: To evaluate the rationality of drug promotional literature (DPL) using World Health Organization (WHO) ethical criteria and to evaluate the perception of clinicians regarding DPLs using prevalidated criteria. …
Article
An Observational Study on the Intraoperative Awareness Following General Anesthetic Drugs
Nikita Haldar, Krishna Prasad T., Mali Kalpana Ramanna, Maduram Annamalai, Soundarya Priyadharsini K.
pp. 47–53 · DOI: 10.1177/0976500X231172579 · Published 2023
Objective: To determine intraoperative awareness and estimate the factors associated with intraoperative awareness. Methods: An observational cross-sectional study was carried out after approval from the institutional et…
Article
Selective Partial Agonism of Vasopressin 1a Receptors In Vitro by OCE-205
Glenn Croston, Edward E. Cable, Jeannine Toy, Hiroe Tariga, Regent Laporte, Geoff Harris, Stan Bukofzer
pp. 54–61 · DOI: 10.1177/0976500X231175220 · Published 2023
Objective: To test the selectivity and degree of functional agonism of Ocelot Bio’s dual agonist/antagonist molecule, OCE-205, at the vasopressin 1a receptor (V1aR). Methods: Cells expressing human (h) or rat V1a, V1b, V…
Article
Influence of miR-142-3p on Pulmonary Fibrosis Through Regulation of p53/NF-κB
Ye Shen, Heng-Jie Li, Ke Zhang, Sheng-Qin Li, Ying-Ge Xu
pp. 62–71 · DOI: 10.1177/0976500X231175222 · Published 2023
Objectives: To investigate the role of miR-142-3p in the bleomycin-induced idiopathic pulmonary fibrosis (IPF) mouse model and elucidate its targets. Methods: In vitro model: Alveolar epithelial cells (AECs) were isolate…
Article
Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study
Velammal Petchiappan, Elsa Mathew, Josna Jose, Mohamed Fardan, Yoganathan Chidambaram, Saravanan Thangavelu
pp. 72–78 · DOI: 10.1177/0976500X231175219 · Published 2023
Objective: To evaluate whether a fixed dose combination (FDC) with remogliflozin and vildagliptin as an add-on therapy can improve the glycemic control in the management of type 2 diabetes mellitus and also the non-glyce…
Article
Effect of Bezafibrate, a PPARα Activator, on Acute and Subacute Inflammation in Male Wistar Rats
Serah Johny, S. S. Torgal
pp. 79–83 · DOI: 10.1177/0976500X231175218 · Published 2023
Aim: To investigate the anti-inflammatory effect of bezafibrate on acute and subacute inflammation in adult male Wistar rats. Methods: The study was carried out in adult male Wistar rats and they were allocated into thre…

Case Report

Article
Challenges in Anesthetic Management of Succinylcholine-induced Masseter Muscle Rigidity in Difficult Airway Patient: A Case Report
Monika Sharma, Aruna Chandak, Priyanka Dev, Aditi Prafulshatalwar
pp. 84–87 · DOI: 10.1177/0976500X231169104 · Published 2023
The difficult airway is already a challenging situation for anesthesiologists, in that scenario Succinylcholine (SCh) use, because of its rapid onset and short duration of action makes it a neuromuscular blockage drug of…